QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2015    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 6 作者:  Li, Jin;  Qin, Shukui;  Xu, Ruihua;  Yau, Thomas C. C.;  Ma, Brigette 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/13 Partial virological response to entecavir treatment in nucleos(t)ide-naive patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity 期刊论文 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 卷号: 464, 期号: 4 作者:  Li, Xinyan;  Li, Fahong;  Zhang, Yao;  Kang, Yaoyue;  Yu, Jie 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19 Chronic hepatitis B  Entecavir  Partial virological response  Genotypic resistance  Phenotypic analysis   Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial. 会议论文 作者:  Qin, Shukui;  Kim, Tae Won;  Yau, Thomas Cheung;  Ma, Brigette 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer 会议论文 作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Keming;  Wu, Gang;  Shi, Chunmei 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19